JAMDA
April 7, 2014
Showing 5171 - 5180 of 8451 results
Caring for the Ages
September 28, 2015
New Treatment Target for Hypothyroid in Elderly Patients
Spotlight
May 5, 2025
New Vice President Wants to Make Sure Your Voices Are Heard
Diane Sanders-Cepeda, DO, CMD, PALTmed’s new vice president, wants every member to know their voice matters. “The knowledge and insights our members have around delivering quality, improving care, and building community define our organization,” she says. “And this is what motivates me, this responsibility...
Caring for the Ages
February 26, 2016
New VTE Guidelines Favor NOACs Over Warfarin
Caring for the Ages
March 2, 2015
New, Limited Rx Coming for Orthostatic Hypotension
Caring for the Ages
October 1, 2025
New, Revised Resources for a Medical Director’s Roles
Sponsored Education
Jun 24, 2025 12:00 pm - Jun 24, 2025 1:00 pm
Newly Approved Treatment in Alzheimer’s Disease
Join us for a live webinar June 24 at 12:00 PM EST and be among the first to learn about a newly approved treatment for Alzheimer’s disease! In collaboration with Alpha Cognition, this edition will educate on the differentiation of the newly approved treatment based on its underlying technology and mechanism of action, as well as review the treatment’s efficacy and safety established from clinical trials and real-world evidence. The speakers, including Michael McFadden, Chief Executive Officer at Alpha Cognition, will enable participants to explore unmet needs in the treatment of Alzheimer’s Disease and learn about a new treatment. Register now.
US-ZUNV-00069 V1
Sponsored Education
Jul 29, 2025 12:00 pm - Jul 29, 2025 1:00 pm
Newly Approved Treatment in Alzheimer’s Disease
Join us for a live webinar July 29 at 12:00 PM EST and be among the first to learn about a newly approved treatment for Alzheimer’s disease! In collaboration with Alpha Cognition, this edition will educate on the differentiation of the newly approved treatment based on its underlying technology and mechanism of action, as well as review the treatment’s efficacy and safety established from clinical trials and real-world evidence. The speakers, including Michael McFadden, Chief Executive Officer at Alpha Cognition, will enable participants to explore unmet needs in the treatment of Alzheimer’s Disease and learn about a new treatment. Register now.
US-ZUNV-00069 V1
Caring for the Ages
July 31, 2015
News From the ASSOCIATION
Caring for the Ages
July 2, 2015
News From the Association
